-
Je něco špatně v tomto záznamu ?
Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining
M. Masarik, J. Gumulec, M. Hlavna, M. Sztalmachova, P. Babula, M. Raudenska, M. Pavkova-Goldbergova, N. Cernei, J. Sochor, O. Zitka, B. Ruttkay-Nedecky, S. Krizkova, V. Adam, R. Kizek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
PubMed
22592803
DOI
10.1039/c2ib00157h
Knihovny.cz E-zdroje
- MeSH
- buňky - růstové procesy účinky léků MeSH
- fluorescenční barviva chemie MeSH
- fluorescenční mikroskopie metody MeSH
- formazany chemie MeSH
- glutathion metabolismus MeSH
- impedanční spektroskopie MeSH
- lidé MeSH
- lineární modely MeSH
- metalothionein genetika metabolismus MeSH
- nádorové buněčné linie MeSH
- nádory prostaty farmakoterapie metabolismus patologie MeSH
- oxidace-redukce MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- RNA chemie genetika MeSH
- síran zinečnatý farmakologie MeSH
- tetrazoliové soli chemie MeSH
- viabilita buněk fyziologie MeSH
- western blotting MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
The present paper is focused on zinc(ii) treatment effects on prostatic cell lines PC-3 (tumour) and PNT1A (non-tumour). Oxidative status of cells was monitored by evaluation of expression of metallothionein (MT) isoforms 1A and 2A at the mRNA and protein level, glutathione (oxidised and reduced), and intracellular zinc(ii) after exposition to zinc(ii) treatment at concentrations of 0-150 μM using electrochemical methods, western blotting and fluorescent microscopy. A novel real-time impedance-based growth monitoring system was compared with widely used end-point MTT assay. Impedance-based IC(50) for zinc(ii) is 55.5 and 150.8 μM for PC-3 and PNT1A, respectively. MTT-determined IC(50) are >1.3-fold higher. Impedance-based viability correlates with viable count (r > 0.92; p < 0.03), not with MTT. Two-fold lower intracellular zinc(ii) in the tumour PC-3 cell line was found. After zinc(ii) treatment >2.6-fold increase of intracellular zinc(ii) was observed in non-tumour PNT1A and in tumour PC-3 cells. In PC-3 cells, free and bound zinc(ii) levels were enhanced more markedly as compared to PNT1A. PNT1A produced 4.2-fold less MT compared to PC3. PNT1A cells showed a 4.8-fold increase trend (r = 0.94; p = 0.005); PC-3 did show a significant trend at MT1 and MT2 protein levels (r = 0.93; p = 0.02) with nearly ten-fold increase after 100 μM zinc(ii) treatment. In terms of redox state, PNT1A had a predominance of reduced GSH forms (GSH : GSSG ratio > 1), when exposed to zinc(ii) compared to PC3, where predominance of oxidised forms remains at all concentrations. IC(50) differs significantly when determined by MTT and real-time impedance-based assays due to dependence of impedance on cell morphology and adhesion. When real-time growth monitoring, precise electrochemical methods and fluorescent microscopy are performed together, accurate information for metal fluxes, their buffering by thiol compounds and monitoring of the redox state become a powerful tool for understanding the role of oxidative stress in carcinogenesis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012676
- 003
- CZ-PrNML
- 005
- 20130611102259.0
- 007
- ta
- 008
- 130404s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1039/c2ib00157h $2 doi
- 035 __
- $a (PubMed)22592803
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Masařík, Michal $7 xx0104244 $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic. masarik@med.muni.cz
- 245 10
- $a Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining / $c M. Masarik, J. Gumulec, M. Hlavna, M. Sztalmachova, P. Babula, M. Raudenska, M. Pavkova-Goldbergova, N. Cernei, J. Sochor, O. Zitka, B. Ruttkay-Nedecky, S. Krizkova, V. Adam, R. Kizek,
- 520 9_
- $a The present paper is focused on zinc(ii) treatment effects on prostatic cell lines PC-3 (tumour) and PNT1A (non-tumour). Oxidative status of cells was monitored by evaluation of expression of metallothionein (MT) isoforms 1A and 2A at the mRNA and protein level, glutathione (oxidised and reduced), and intracellular zinc(ii) after exposition to zinc(ii) treatment at concentrations of 0-150 μM using electrochemical methods, western blotting and fluorescent microscopy. A novel real-time impedance-based growth monitoring system was compared with widely used end-point MTT assay. Impedance-based IC(50) for zinc(ii) is 55.5 and 150.8 μM for PC-3 and PNT1A, respectively. MTT-determined IC(50) are >1.3-fold higher. Impedance-based viability correlates with viable count (r > 0.92; p < 0.03), not with MTT. Two-fold lower intracellular zinc(ii) in the tumour PC-3 cell line was found. After zinc(ii) treatment >2.6-fold increase of intracellular zinc(ii) was observed in non-tumour PNT1A and in tumour PC-3 cells. In PC-3 cells, free and bound zinc(ii) levels were enhanced more markedly as compared to PNT1A. PNT1A produced 4.2-fold less MT compared to PC3. PNT1A cells showed a 4.8-fold increase trend (r = 0.94; p = 0.005); PC-3 did show a significant trend at MT1 and MT2 protein levels (r = 0.93; p = 0.02) with nearly ten-fold increase after 100 μM zinc(ii) treatment. In terms of redox state, PNT1A had a predominance of reduced GSH forms (GSH : GSSG ratio > 1), when exposed to zinc(ii) compared to PC3, where predominance of oxidised forms remains at all concentrations. IC(50) differs significantly when determined by MTT and real-time impedance-based assays due to dependence of impedance on cell morphology and adhesion. When real-time growth monitoring, precise electrochemical methods and fluorescent microscopy are performed together, accurate information for metal fluxes, their buffering by thiol compounds and monitoring of the redox state become a powerful tool for understanding the role of oxidative stress in carcinogenesis.
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a buňky - růstové procesy $x účinky léků $7 D048708
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a viabilita buněk $x fyziologie $7 D002470
- 650 _2
- $a impedanční spektroskopie $7 D058266
- 650 _2
- $a fluorescenční barviva $x chemie $7 D005456
- 650 _2
- $a formazany $x chemie $7 D005562
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metalothionein $x genetika $x metabolismus $7 D008668
- 650 _2
- $a fluorescenční mikroskopie $x metody $7 D008856
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a nádory prostaty $x farmakoterapie $x metabolismus $x patologie $7 D011471
- 650 _2
- $a RNA $x chemie $x genetika $7 D012313
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a tetrazoliové soli $x chemie $7 D013778
- 650 _2
- $a síran zinečnatý $x farmakologie $7 D019287
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gumulec, Jaromír, $d 1963- $7 xx0054104
- 700 1#
- $a Hlavna, Marian. $7 _AN049680
- 700 1_
- $a Sztalmachová, Markéta $7 xx0146032
- 700 1_
- $a Babula, Petr
- 700 1#
- $a Raudenská, Martina, $d 1980- $7 hka2015854485
- 700 1_
- $a Pávková Goldbergová, Monika $7 xx0054290
- 700 1#
- $a Cernei, Natalia. $7 _AN063287
- 700 1#
- $a Sochor, J. $7 _AN063450
- 700 1_
- $a Zítka, Ondřej $7 xx0116134
- 700 1#
- $a Ruttkay-Nedecký, Branislav. $7 xx0237909
- 700 1_
- $a Křížková, Soňa, $d 1981- $7 xx0105812
- 700 1_
- $a Adam, Vojtěch, $d 1982- $7 xx0064599
- 700 1_
- $a Kizek, René, $d 1972- $7 jn20001005291
- 773 0_
- $w MED00181432 $t Integrative biology : quantitative biosciences from nano to macro $x 1757-9708 $g Roč. 4, č. 6 (2012), s. 672-84
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22592803 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130611102641 $b ABA008
- 999 __
- $a ok $b bmc $g 975874 $s 810957
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 4 $c 6 $d 672-84 $i 1757-9708 $m Integrative biology $n Integr Biol (Camb) $x MED00181432
- LZP __
- $a Pubmed-20130404